Open original FDA record ↗Recall record
- FDA identifier
- Z-0849-2015
- Company in FDA record
- Illumina Inc
- FDA classification date
- Dec 23, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
It was discovered a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Universal Kit 1.0 on the MiSeqDx instrument. The software cannot report insertions or deletions at specific genomic locations with respect to the primer.
Source facts
- Action
- A customer letter dated November 13, 2014, was sent to all customers who is using the MiSeqDx Universal Kit 1.0 on the MiSeqDx instrument. The letter informs the customers that Illumina has recently confirmed a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Universal Kit 1.0 on the MiSeqDx instrument. The software cannot report insertions or deletions at specific genomic locations with respect to the primer. The customer notification outlines the potential issues, the results of investigation, actions required, and next steps. Customers are instructed to return the attached Verification form to confirm their receipt of the letter and document the results of any patient impact from the limitation. Customers with technical questions or concerns, are instructed to contact their local support team or Illumina Technical Support at techsupport@illumina.com. Customers with questions regarding the field action, are instructed to contact Illumina Regulatory Affairs at RA@illumina.com. For further questions, please call (858) 736-3861.
- Initiated
- 2014-11-13
- Root cause
- Software design
- Terminated
- 2015-03-18
- Distribution
- US Distribution to the states of AZ, GA, CA, OH, and VA., and one Internationally to France.
- Recall number
- Z-0849-2015
- Recall status
- Terminated
- CDRH record ID
- 131490
- FDA classified
- 2014-12-23
- Recall event number
- 69766